Roivant Sciences (ROIV) Shares Outstanding (Entity) (2020 - 2026)

Roivant Sciences (ROIV) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 722.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 722.67 Mn
Mar 31, 2026 720.35 Mn
Dec 31, 2025 709.69 Mn
Sep 30, 2025 689.70 Mn
Jun 30, 2025 682.23 Mn
Mar 31, 2025 695.94 Mn
Dec 31, 2024 719.63 Mn
Sep 30, 2024 733.33 Mn
Jun 30, 2024 739.05 Mn
Mar 31, 2024 806.68 Mn
Dec 31, 2023 804.89 Mn
Sep 30, 2023 800.79 Mn
Jun 30, 2023 767.14 Mn
Mar 31, 2023 760.14 Mn
Dec 31, 2022 726.80 Mn
Sep 30, 2022 704.39 Mn
Jun 30, 2022 701.17 Mn
Mar 31, 2022 694.98 Mn
Dec 31, 2021 692.01 Mn
Sep 30, 2021 684.79 Mn